What is the Somogyi Effect?

Insulin therapy plays a vital role in managing diabetes for many individuals. By reducing blood sugar levels, insulin helps counter the spike that occurs after meals. However, some people with diabetes may experience unusually high blood sugar levels in the morning. This phenomenon, known as the Somogyi effect or chronic Somogyi rebound, typically happens when insulin is administered before bedtime. Although widely discussed, the theories surrounding the Somogyi effect lack solid scientific evidence and have been a subject of controversy.


Michael Somogyi: Pioneer in Diabetes Research

Michael Somogyi, a renowned biochemist hailing from Hungary, made significant contributions to the field of diabetes research. He held a prominent position as a professor of biochemistry at Washington University and later served as the first chemist at the Jewish Hospital of St. Louis. In 1922, Somogyi achieved a groundbreaking milestone by administering the first-ever insulin treatment to a child with diabetes. Throughout his career, he dedicated his efforts to studying the impact of insulin on patients with diabetes. In 1938, Somogyi presented his research findings, unveiling what is now known as the Somogyi effect.


The Impact of Insulin Therapy on Diabetes

Insulin therapy is a common treatment for individuals with diabetes, but it can have unintended consequences. One theory, proposed by Somogyi, suggests that insulin therapy itself may contribute to unstable diabetes. Normally, insulin is administered to regulate high blood sugar levels or hyperglycemia. However, an excessive amount of insulin can lead to dangerously low blood sugar levels, known as hypoglycemia. Somogyi hypothesized that untreated hypoglycemia could trigger a rebound effect, causing a spike in blood sugar levels.

Specifically, when an individual takes too much insulin at night, they may experience hypoglycemia while asleep. In response, the body releases various hormones, including glucagon, epinephrine, cortisol, and growth hormone. Glucagon prompts the liver to release glucose, causing blood sugar levels to rise. Simultaneously, the other hormones create resistance to insulin, further exacerbating the instability of blood sugar levels.

PREV1 of 5